ResearcherIcahn School of Medicine at Mount SinaiActive in the last 2 years

Emma W. Gong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8728-2247; OpenAlex author ID A5114156918. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy. Co-author DOI 10.1093/jncics/pkaf024 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Deirdre Jill Cohen · 1 shared paper, 2025 · strength 0.28
- Paper Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving che… DOI 10.1093/jncics/pkaf024 ↗
Arielle J. Labiner · 1 shared paper, 2025 · strength 0.28
- Paper Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving che… DOI 10.1093/jncics/pkaf024 ↗
Keith Magnus Sigel · 1 shared paper, 2025 · strength 0.28
- Paper Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving che… DOI 10.1093/jncics/pkaf024 ↗
Daniel Jeremy Fulop · 1 shared paper, 2025 · strength 0.28
- Paper Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving che… DOI 10.1093/jncics/pkaf024 ↗
Aimee Lee Lucas · 1 shared paper, 2025 · strength 0.28
- Paper Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving che… DOI 10.1093/jncics/pkaf024 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.